Elsevier

The Journal of Pediatrics

Volume 131, Issue 3, September 1997, Pages 434-439
The Journal of Pediatrics

Topical iodine-containing antiseptics and subclinical hypothyroidism in preterm infants

https://doi.org/10.1016/S0022-3476(97)80071-6Get rights and content

The influence of topical iodine-containing antiseptics on thyroid function test results of premature infants was determined in two separate studies. Thyroxine and thyrotropin levels were measured on blood-spotted filter paper. Samples were obtained from 128 premature infants on their tenth day of life; the infants were treated in two neonatal intensive care units. Both units used similar treatment protocols; however, one routinely used topical iodinated antiseptic agents (n = 73), whereas the other used chlorhexidinecontaining antiseptics (n = 55). There was no difference in the mean T4 levels between the two groups. The mean thyrotropin levels were elevated in preterm babies exposed to iodine (15.4 vs 7.8 mIU/L, p < 0.01). Among the iodine-exposed infants, elevated thyrotropin levels (>30 mIU/L) were found in 13.7% of infants, compared with none in the chlorhexidine-treated group (p < 0.01). We then studied an additional 46 premature infants who were treated in one neonatal intensive care unit. Iodine-containing solutions were used in 24 infants and chlorhexidine was used in 22 infants. T4 and thyrotropin levels were measured weekly during the first 28 days, once every 2 weeks until the age of 60 days, and at the age of 90 days. Among iodine-exposed infants, 20.8% had thyrotropin values >30 mIU/L, whereas none of the infants in the chlorhexidine group had elevated thyrotropin values (p < 0.05). The elevated thyrotropin levels correlated positively with the area of disinfection. Elevated urine iodine levels were present reflecting an abnormally high iodine absorption. This study suggests that iodine absorption from topical iodine-containing antiseptics may cause disturbances in thyroid function test results in premature infants. We recommend that caution be exercised in the use of iodine-containing antiseptics in premature infants.

References (29)

  • WawschinekO et al.

    Bestimmung der harnjodansscheidung mittels einer modi-fizierten Cer-Arsenitmethode

    Berichte OGKC

    (1985)
  • SilvaJE

    Effects of iodine containing com-pounds on thyroid function

    Med Clin North Am

    (1985)
  • FisherDA

    Thyroid physiology in the perinatal period and during childhood

  • Cited by (119)

    • Iodine Status of Preterm Infants Born in an Area of Iodine Sufficiency: Are They at Risk of Iodine Deficiency?

      2022, Endocrine Practice
      Citation Excerpt :

      In our study, preterm infants demonstrated evidence of iodine deficiency during early postnatal life using 2 different indices of iodine status. Historically, there have been concerns about premature infants being vulnerable to hypothyroidism from iodine excess because of the widespread use of iodinated skin cleansers, such as povidone-iodine in NICUs.20-23 However, a decrease in the use of these cleansers in recent years in Iran and elsewhere24-26 can be a potential factor for the negative iodine balance in this vulnerable group.

    • Infection Prevention in the Neonatal Intensive Care Unit

      2021, Clinics in Perinatology
      Citation Excerpt :

      Povidone-iodine is routinely used for skin preparation before obtaining blood cultures and before performing surgical procedures. Associated harms include rare reports of systemic absorption with associated hypothyroidism in neonates.38 Chlorhexidine is increasingly used in the NICU, for skin preparation before procedures, Staphylococcus aureus decolonization, and bathing for CLABSI prevention.18,39,40

    • Iodine complexed poly(vinyl pyrrolidone) plasma polymers as broad-spectrum antiseptic coatings

      2021, Applied Surface Science
      Citation Excerpt :

      For instance, post-operative adverse health events including renal failure or impairment, hypothyroidism, thyrotoxosis and seisure have been noted [22,23], however, it has been suggested that often these have been falsely attributed to iodophoric antiseptic agents and are more likely related to unrecognised underlying pathologies [21]. Incidentally, numerous case studies have shown that there are no detrimental effects from the perioperative application of PVP-I based antiseptics [23–25]. PVP-I is commercially formulated as disinfectant scrubs, gels, ointments, solutions and swabs, yet there are few examples of its adaptation for use in an effective surface coating [8].

    View all citing articles on Scopus
    View full text